<DOC>
	<DOC>NCT02969941</DOC>
	<brief_summary>To investigate the treatment effect of continuous transcranial magnetic stimulation on patients with Parkinson disease, and the underlying neural mechanism by functional MRI</brief_summary>
	<brief_title>Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment for Parkinson Disease</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Diagnosis of Parkinson disease (PD) according to the United Kingdom Brain Bank Criteria, confirmed by a neurologist with expertise in movement disorders. Minimum of 3 years since the formal diagnosis of PD, and requiring dopaminergic therapy (at a minimum, on levodopa and/or dopamine agonist therapy). On a stable dose of all medications for 2 months; and no antiPD medication adjustments in the next 3 months. Age 40 years or older. Minimental state examination &gt; 27. Any history or clinical signs of other severe psychiatric illnesses (like major depression, psychosis or obsessive compulsive disorder). History of head injury, stroke, or other neurologic disease. Organic brain defects on T1 or T2 images. History of seizures or unexplained loss of consciousness. Implanted pacemaker, medication pump, vagal stimulator, deep brain stimulator. Family history of medication refractory epilepsy. History of substance abuse within the last 6 months.</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Parkinson Disease</keyword>
	<keyword>Functional Magnetic Resonance Imaging</keyword>
	<keyword>Transcranial Magnetic Stimulation</keyword>
</DOC>